Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News Alert: FDA details new risk with heart pump controllers after patient’s death

News You Need to Know Today
News Alert: FDA details new risk with heart pump controllers after patient’s death
Wednesday, August 27, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA details new risk with Johnson & Johnson heart pump controllers after patient’s death

This latest alert was put in place after Johnson & Johnson MedTech learned that some of its Automated Impella Controllers were built to the wrong specifications, impacting their ability to function. Affected devices should not be used going forward.

READ MORE >
Johnson & Johnson MedTech Automated Impella Controller
Share on Twitter Share on Facebook Share on Linkedin

FDA details new risk with Johnson & Johnson heart pump controllers after patient’s death

Share on Twitter Share on Facebook Share on Linkedin
Johnson & Johnson MedTech Automated Impella Controller
This latest alert was put in place after Johnson & Johnson MedTech learned that some of its Automated Impella Controllers were built to the wrong specifications, impacting their ability to function. Affected devices should not be used going forward.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

The many challenges hospitals face during COVID-19 pandemic | Are patients afraid to seek medical attention?
Providing emergency care for children with COVID-19 | AI assesses cardiac function faster than cardiologists
Pandemic watch: The biggest COVID-19 news in cardiology, all in one place
Week in Review: When the risk of death from COVID-19 skyrockets | Burnout in cardiology | Hypertension & COVID-19
Stroke surgeons share COVID-19 warning | Cardiologist-led COVID-19 research | E-cigarettes & smoking
Hypertension | April 2020
Month in Review: 10 Trending Stories from March

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …346
    • Page 347
    • Page 348
    • Page 349
    • Current page 350
    • Page 351
    • Page 352
    • Page 353
    • Page 354
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup